Translational Development Acquisition Corp. (NASDAQ:TDACU) Sees Large Decline in Short Interest

Translational Development Acquisition Corp. (NASDAQ:TDACU) saw a significant drop in short interest in the month of June. As of June 15th, there was short interest totaling 1 shares, a drop of 99.0% from the May 31st total of 96 shares. Based on an average trading volume of 2,417 shares, the days-to-cover ratio is presently 0.0 days.

Translational Development Acquisition Stock Up 3.0%

Shares of NASDAQ:TDACU opened at $12.36 on Friday. The company has a 50 day moving average of $11.45 and a 200 day moving average of $10.83. Translational Development Acquisition has a 12 month low of $10.71 and a 12 month high of $17.29.

About Translational Development Acquisition

Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.

In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.

Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.